loadpatents
name:-0.026076078414917
name:-0.007267951965332
name:-0.005885124206543
GOLFIER; Sven Patent Filings

GOLFIER; Sven

Patent Applications and Registrations

Patent applications and USPTO patent grants for GOLFIER; Sven.The latest application filed is for "inhibitor of atr kinase for use in a method of treating a hyper-proliferative disease".

Company Profile
4.6.24
  • GOLFIER; Sven - Berlin DE
  • Golfier; Sven - US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Inhibitor Of Atr Kinase For Use In A Method Of Treating A Hyper-proliferative Disease
App 20210404012 - WENGNER; Antje Margret ;   et al.
2021-12-30
Anti-ceacam6 Antibodies And Uses Thereof
App 20200181261 - WILLUDA; Jorg ;   et al.
2020-06-11
Anti-ceacam6 Antibodies And Uses Thereof
App 20200157214 - WILLUDA; Jorg ;   et al.
2020-05-21
Anti-CEACAM6 antibodies and uses thereof
Grant 10,584,167 - Willuda , et al.
2020-03-10
An Inhibitor Of Atr Kinase For Use In A Method Of Treating A Hyper-proliferative Disease
App 20200063212 - WENGNER; Antje Margret ;   et al.
2020-02-27
Anti-ceacam6 Antibodies And Uses Thereof
App 20180162940 - WILLUDA; Jorg ;   et al.
2018-06-14
Anti-tweakr Antibodies And Uses Thereof
App 20160237160 - VOTSMEIER; Christian ;   et al.
2016-08-18
New Binder-drug Conjugates (adcs) And Use Thereof
App 20160193359 - LERCHEN; Hans-Georg ;   et al.
2016-07-07
NOVEL BINDER-DRUG CONJUGATES (ADCs) AND USE OF SAME
App 20150246136 - LERCHEN; Hans-Georg ;   et al.
2015-09-03
N-carboxyalkyl-auristatin And Use Thereof
App 20150148298 - LERCHEN; Hans-Georg ;   et al.
2015-05-28
Binder-drug conjugates (ADCs) and use thereof
Grant 8,992,932 - Lerchen , et al. March 31, 2
2015-03-31
N-carboxyalkyl-auristatin and the use thereof
Grant 8,987,209 - Lerchen , et al. March 24, 2
2015-03-24
Novel Binder-drug Conjugates (adcs) And Use Thereof
App 20150030618 - LERCHEN; Hans-Georg ;   et al.
2015-01-29
New Antibody Drug Conjugates (adcs) And The Use Thereof
App 20150023989 - Lerchen; Hans-Georg ;   et al.
2015-01-22
Anti-FGFR2 Antibodies and Uses Thereof
App 20140322220 - Harrenga; Axel ;   et al.
2014-10-30
Auristatin derivatives and use thereof
Grant 8,722,629 - Lerchen , et al. May 13, 2
2014-05-13
Novel Binder-Drug Conjugates (ADCs) and Use of Same
App 20140127240 - Lerchen; Hans-Georg ;   et al.
2014-05-08
N-carboxyalkyl-auristatin And The Use Thereof
App 20130261064 - Lerchen; Hans-Georg ;   et al.
2013-10-03
Novel Auristatin Derivatives And Use Thereof
App 20130157960 - Lerchen; Hans-Georg ;   et al.
2013-06-20
New Binder-drug Conjugates (adcs) And Use Thereof
App 20130122024 - LERCHEN; Hans-Georg ;   et al.
2013-05-16
New binder-drug conjugates (ADCs) and use thereof
App 20130095123 - Lerchen; Hans-Georg ;   et al.
2013-04-18
New Binder-drug Conjugates (adcs) And Use Thereof
App 20130066055 - Lerchen; Hans-Georg ;   et al.
2013-03-14
Use Of High-doses Of Monomeric Contrast Medium Containing Iodine In X-ray Diagnostics, In Particular In Interventional X-ray Diagnostics And In Radiation Therapy Assisted By Contrast Media Containing Iodine
App 20120134933 - Jost; Gregor ;   et al.
2012-05-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed